You are here

Home › Moderna's Omicron-specific booster could start clinical trials early next year › Moderna's Omicron-specific booster could start clinical trials early next year

Moderna's Omicron-specific booster could start clinical trials early next year

Primary tabs

Moderna's Omicron-specific booster could start clinical trials early next year

Mon, 2021-12-20 09:39 — mike kraft
Moderna's Omicron-specific booster could start clinical trials early next year Biotechnology company Moderna continues to work on developing Covid-19 boosters that specifically target certain variants, including Delta and Omicron, Dr. Stephen Hoge, president of the company, said Monday. By Jack Guy and Aditi Sangal CNN

...

"We're going to continue to advance an Omicron-specific booster into clinical trials in early 2022," Hoge said during a company conference call.

For now, Moderna plans to focus its "immediate efforts" around Omicron on advancing the current vaccine that is already available, Hoge said.

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Disease Prevention
Health
Mutations
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
Health - US
RAC Vaccines and Vaccination Group
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks